AMIPAQUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amipaque, and when can generic versions of Amipaque launch?
Amipaque is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in AMIPAQUE is metrizamide. There is one drug master file entry for this compound. Additional details are available on the metrizamide profile page.
Summary for AMIPAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 14 |
Patent Applications: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMIPAQUE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AMIPAQUE
US Patents and Regulatory Information for AMIPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-003 | Sep 12, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-004 | Sep 12, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AMIPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AMIPAQUE
See the table below for patents covering AMIPAQUE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 7004404 | ⤷ Try a Trial | |
Israel | 34803 | ⤷ Try a Trial | |
France | 2053037 | ⤷ Try a Trial | |
Philippines | 10017 | NOVEL IODINATED X-RAY CONTRAST AGENTS | ⤷ Try a Trial |
Denmark | 130709 | ⤷ Try a Trial | |
Sweden | 392100 | TRIJODBENSOYLAMINER TILL ANVENDNING SASOM RONTGENKONTRASTMEDEL ELLER FOR SEPARATION AV BIOLOGISKA MATERIAL | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |